Iradimed IRMD
NASDAQ IRMD
$87.70 +0.30 (+0.34%)
At close: Aug 20, 2026 · 12:05 PM UTC

Iradimed (IRMD) EBT Margin (2013 - 2026)

Iradimed (IRMD) posted quarterly EBT Margin of 33.66% for Q2 2026, down 225.0% year-over-year from 26.92% in Q2 2025, and down 4.79% on a QoQ basis from 35.35% in Q1 2026.

Iradimed (IRMD) EBT Margin (2013 - 2026) Analysis & Trends

Iradimed has reported EBT Margin for 14 years, with the latest figure at 33.66% in Q2 2026.

  • EBT Margin for Q2 2026 came in at 33.66%, down 225.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 34.45% (up 92.0% YoY), and the FY2025 annual result was 33.84%, up 69.0% from the prior year.
  • EBT Margin fell to 33.66% in Q2 2026, from 35.35% in the prior quarter.
  • Over five years, EBT Margin peaked at 38.83% in Q3 2023 and troughed at 24.86% in Q1 2022.
  • A 5-year average of 32.77% and a median of 32.85% in 2022 frame the typical range for EBT Margin.
  • The widest annual swing landed in 2022, when EBT Margin jumped 1392 bps; it then tumbled 381 bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 31.64% in 2022, then gained by 3 bps to 32.56% in 2023, then advanced by 1 bps to 32.72% in 2024, then rose by 5 bps to 34.33% in 2025, then decreased by 2 bps to 33.66% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 33.66% in Q2 2026, 35.35% in Q1 2026, and 34.33% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 12.10%
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn 23.74%
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn 18.70%
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 19.48%
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn 29.86%
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn 24.27%
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn 13.09%
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn 8.91%
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn 18.32%
10 Iradimed 1.12 Bn 1.06 Bn 15.16 Mn 33.66%

Historic Data

Download Data
DateValue
Jun 30, 2026 33.66%
Mar 31, 2026 35.35%
Dec 31, 2025 34.33%
Sep 30, 2025 34.42%
Jun 30, 2025 35.90%
Mar 31, 2025 30.47%
Dec 31, 2024 32.72%
Sep 30, 2024 35.02%
Jun 30, 2024 34.97%
Mar 31, 2024 29.80%
Dec 31, 2023 32.56%
Sep 30, 2023 38.83%
Jun 30, 2023 32.85%
Mar 31, 2023 28.11%
Dec 31, 2022 31.64%
Sep 30, 2022 31.61%
Jun 30, 2022 32.86%
Mar 31, 2022 24.86%
Dec 31, 2021 26.22%
Sep 30, 2021 28.37%